Refractory Celiac Disease

Georgia Malamut, Joseph A. Murray, Christophe Cellier

Research output: Contribution to journalReview article

15 Scopus citations

Abstract

A small subset of patients with celiac disease become refractory to a gluten-free diet, with persistent or recurrent symptoms of malabsorption and intestinal villous atrophy. This condition, defined as refractory celiac disease (RCD), is diagnosed after other small bowel diseases with villous atrophy are excluded. RCD is subdivided into 2 subgroups: type I RCD and type II RCD (RCDII). This latter condition is considered a low-grade intraepithelial lymphoma and has a poor prognosis. This article reviews the clinical and pathologic features of RCD and recent pathogenic findings in RCDII, offering a model to study how inflammation can drive T-cell lymphomagenesis.

Original languageEnglish (US)
Pages (from-to)759-772
Number of pages14
JournalGastrointestinal Endoscopy Clinics of North America
Volume22
Issue number4
DOIs
StatePublished - Oct 1 2012

Keywords

  • Aberrant intraepithelial lymphocytes
  • Immunosuppressive treatments
  • Refractory celiac disease

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Refractory Celiac Disease'. Together they form a unique fingerprint.

  • Cite this